Biondvax

Developer of a vaccine against influenza virus

placeNess Ziona, Center District, Israel calendar_todayFounded 2003 language biondvax.com

Registered entities

Social engagement

Social engagement: 4.1K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital133%
Private equity267%

Recent activity

8 May 2026
Event
7th Annual Dermatology Drug Development Summit Europe
22 Apr 2026
Milestone
revenue
16 Apr 2026
Milestone
revenue
Coming soon